Table 1.
Diagnoses and comorbidities
| Variable | Number of toes | p value | ||
|---|---|---|---|---|
| All toes (n = 135) | SS K wire group (n = 81) | Ti K wire group (n = 54) | ||
| Diagnosis | ||||
| Hammer/claw toe | 100 (74%) | 55 (68%) | 45 (83%) | 0.048 |
| Rheumatoid arthritis | 9 (7%) | 7 (9%) | 2 (4%) | 0.315 |
| Hammer/claw toe (reoperation)* | 14 (10%) | 11 (14%) | 3 (6%) | 0.160 |
| Hallux valgus | 3 (2%) | 2 (3%) | 1 (2%) | 1.000 |
| Other | 9 (7%) | 6 (7%) | 3 (6%) | 0.741 |
| Comorbidities | ||||
| No comorbidities | 108 (80%) | 66 (82%) | 42 (78%) | 0.663 |
| Diabetes | 2 (2%) | 2 (3%) | 0 (0%) | 0.516 |
| Rheumatoid arthritis | 9 (7%) | 7 (9%) | 2 (4%) | 0.315 |
| Additional complex surgery | 12 (9%) | 6 (7%) | 6 (11%) | 0.542 |
| Charcot’s disease | 4 (3%) | 0 (0%) | 4 (7%) | 0.024 |
* Hammer/claw toe deformity after prior operative correction; SS = stainless steel; Ti = titanium.